Vestal Point Capital »

Veracyte shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Veracyte (VCYT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Veracyte

Tip: Access up to 7 years of quarterly data

All positions including Veracyte held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veracyte by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 131k 32.21

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Veracyte

BlackRock
Vanguard Group
FMR
Artisan Partners Limited Partnership
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
ARK Investment Management
Dimensional Fund Advisors
First Trust Advisors
Wellington Management Company
Geode Capital Management
Bank of America Corporation
Jennifer Ranahan
Hanna Zanoni

View all funds holding Veracyte